FIT Biotech Oy (OHEL:FITBIO) Gross Margin % : 0.00% (As of Jun. 2018)

View and export this data going back to 2015. Start your Free Trial

What is FIT Biotech Oy Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. FIT Biotech Oy's Gross Profit for the six months ended in Jun. 2018 was €-0.20 Mil. FIT Biotech Oy's Revenue for the six months ended in Jun. 2018 was €0.00 Mil. Therefore, FIT Biotech Oy's Gross Margin % for the quarter that ended in Jun. 2018 was 0.00%.

The historical rank and industry rank for FIT Biotech Oy's Gross Margin % or its related term are showing as below:

OHEL:FITBIO' s Gross Margin % Range Over the Past 10 Years
Min: -1440 Med: 63.34 Max: 83.47
Current: -1440

During the past 5 years, the highest Gross Margin % of FIT Biotech Oy was 83.47%. The lowest was -1440.00%. And the median was 63.34%.

OHEL:FITBIO's Gross Margin % is not ranked
in the Biotechnology industry.
Industry Median: 60.875 vs OHEL:FITBIO: -1440.00

FIT Biotech Oy had a gross margin of % for the quarter that ended in Jun. 2018 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for FIT Biotech Oy was 0.00% per year.

FIT Biotech Oy Gross Margin % Historical Data

The historical data trend for FIT Biotech Oy's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FIT Biotech Oy Gross Margin % Chart

FIT Biotech Oy Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Gross Margin %

83.47

76.67

50.00

-3,660.00

FIT Biotech Oy Semi-Annual Data
	Dec13	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18
Gross Margin %	Get a 7-Day Free Trial				-540.00	-	-	-	-

Competitive Comparison of FIT Biotech Oy's Gross Margin %

For the Biotechnology subindustry, FIT Biotech Oy's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

FIT Biotech Oy's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, FIT Biotech Oy's Gross Margin % distribution charts can be found below:

* The bar in red indicates where FIT Biotech Oy's Gross Margin % falls into.

FIT Biotech Oy Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

FIT Biotech Oy's Gross Margin for the fiscal year that ended in Dec. 2017 is calculated as

Gross Margin % (A: Dec. 2017 )	=	Gross Profit (A: Dec. 2017 )	/	Revenue (A: Dec. 2017 )
	=	-0.4	/	0
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(0 - 0.428)	/	0
	=	%

FIT Biotech Oy's Gross Margin for the quarter that ended in Jun. 2018 is calculated as

Gross Margin % (Q: Jun. 2018 )	=	Gross Profit (Q: Jun. 2018 )	/	Revenue (Q: Jun. 2018 )
	=	-0.2	/	0
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(0 - 0.198)	/	0
	=	%

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

FIT Biotech Oy (OHEL:FITBIO) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

FIT Biotech Oy had a gross margin of % for the quarter that ended in Jun. 2018 => No sustainable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

FIT Biotech Oy Gross Margin % Related Terms

Thank you for viewing the detailed overview of FIT Biotech Oy's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

FIT Biotech Oy Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FIT Biotech Oy (OHEL:FITBIO) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Biokatu 12, Tampere, FIN, FI-33520

Website

http://www.fitbiotech.com

FIT Biotech Oy is a clinical-stage biotechnology company. It is primarily focused on developing antibody therapies for cancer immunotherapy as well as Deoxyribonucleic acid (DNA) vaccines for the prevention of infectious diseases such as Human immunodeficiency virus (HIV). The firm's GTU technology enables the production of antibodies in the human body instead of using industrially manufactured antibodies. The GTU technology platform has various application areas. The group generates revenue through the sales of services related to the HIV vaccine. The organization is based in Finland.

FIT Biotech Oy Headlines

No Headlines